China’s pioneering ‘flying hospital,’ a collaborative initiative between the Eye and ENT Hospital of Fudan University and the Commercial Aircraft Corporation of China, has achieved a significant milestone. Equipped with a newly upgraded Class 1 clean operating room, the aircraft is now capable of performing both ophthalmology and otorhinolaryngology surgeries. This advancement marks a critical step in China’s efforts to establish a high-level aviation medical system and enhance precision healthcare delivery via air platforms. The project, which began with a focus on ophthalmology, has now expanded to include ENT services, setting a global precedent in aviation medicine. The flying hospital, operating from a domestically manufactured aircraft, completed its first mission on September 5, transporting over 30 medical professionals from Shanghai to Shihezi in Xinjiang. During this mission, the aircraft provided advanced diagnostic services to nearly 50 patients, leveraging 5G technology for remote consultations with specialists in Shanghai. The addition of the operating room aligns with directives from the National Health Commission to improve cataract surgery capabilities in rural areas and accelerate in-flight surgical development. The operating room features customized domestic equipment and a bolt-free design, enabling rapid installation within eight hours. Innovations such as a variable wind speed laminar flow module have overcome technical challenges, making it possible to integrate surgical functions into the aircraft cabin. The hospital plans to begin with cataract surgeries, addressing high demand in underserved regions, and expand to common ENT procedures like nasal polyp and sinusitis operations. This initiative not only improves access to quality healthcare in remote areas but also strengthens China’s emergency medical response capabilities.
分类: health
-

Study finds young-onset dementia outpacing late-onset dementia in China
A groundbreaking study published in *The Journal of Prevention of Alzheimer’s Disease* has unveiled a concerning trend in China: the growth rate of young-onset dementia (YOD) is now significantly outpacing that of late-onset dementia (LOD). The research, which analyzed data from the Global Burden of Disease study spanning 1990 to 2021, highlights a critical shift in the burden of dementia across age groups. While the total number of LOD cases remains higher, the incidence and prevalence of YOD—defined as onset before age 65—have surged more sharply since 2012. This alarming trend underscores the urgent need for early intervention and preventive measures. Dr. Han Ying, a leading cognitive disorders specialist at Xuanwu Hospital in Beijing, emphasized that dementia prevention must begin as early as age 40, particularly for individuals in the prime of their careers and family responsibilities. The study also identified key modifiable risk factors for both YOD and LOD, including tobacco use, high fasting plasma glucose, and high body mass index (BMI). Notably, these risk factors exhibit significant gender-based variations, with tobacco use posing a greater threat to men and high glucose levels and BMI affecting women more severely. Dr. Han urged the public to adopt healthier lifestyles and prioritize brain health from midlife to mitigate these risks.
-

Irish government approves plans to ban disposable vapes
The Irish government has taken a decisive step to curb nicotine addiction among young people by approving a comprehensive ban on disposable vapes and introducing stringent regulations on other nicotine products. This move follows Northern Ireland’s earlier prohibition on the sale and supply of single-use vapes in April 2025. Under the new legislation, retailers in the Republic of Ireland found selling disposable e-cigarettes could face severe penalties, including up to two years in prison and fines of up to £5,000. Health Minister Jennifer Carroll MacNeill emphasized that the Public Health (Single Use Vapes) Bill 2025 aims to shield children from the allure of nicotine products. The government also plans to restrict the sale of nicotine pouches to individuals under 18 and ban advertising for such products in retail outlets. These measures will be integrated into the Public Health (Tobacco Products and Nicotine Inhaling Products) (Amendment) Bill, which will regulate packaging, flavors, and product displays. Both Carroll MacNeill and Minister of State Jennifer Murnane O’Connor pledged to expedite the implementation of these laws, highlighting their commitment to safeguarding the health of future generations.
-

Fitness center targets seniors with chronic conditions
In response to China’s rapidly aging population and the increasing prevalence of chronic diseases, a community fitness center in Tianjin’s Hedong district is leading the charge in senior health management. Launched in August 2025, the Fuminlu Community Health Service Center has introduced tailored exercise programs designed to address chronic conditions such as cardiovascular disease, diabetes, and respiratory illnesses. With over 1,000 participants already enrolled, the center combines medical expertise with fitness training to offer a holistic approach to health.
-

Call My Doctor launches digital platform to strengthen UAE’s home healthcare ecosystem
Call My Doctor Health Care LLC, a prominent Dubai-based home healthcare provider, has unveiled a cutting-edge digital platform aimed at revolutionizing the home healthcare ecosystem in the UAE. The newly launched website is designed to streamline the booking of essential medical services, catering to residents and visitors across the Emirates. This initiative reflects the region’s shift towards fast, convenient, and patient-centric healthcare solutions.
The platform enables users to request licensed doctors, nurses, and specialists for home visits, often within 30 minutes. It addresses the growing demand for home-based care among elderly individuals, children, working professionals, and those with mobility challenges, who benefit from receiving treatment in a familiar and comfortable environment. Since its establishment in 2022, Call My Doctor has conducted over 10,000 home visits, offering services such as Doctor on Call, IV Therapy, Lab Tests, Physiotherapy, Nursing, and Pediatric Care, all delivered by Dubai Health Authority (DHA)-licensed practitioners.
Jay Aondhiya, founder and CEO of Call My Doctor, emphasized the company’s mission to make healthcare fast, personal, and professional. ‘Our new website empowers patients to connect with DHA-licensed experts within minutes, ensuring that healthcare in Dubai remains efficient, compassionate, and accessible,’ he stated. The platform allows users to browse services, book consultations, and receive timely updates, all while adhering to DHA guidelines and national health standards.
Call My Doctor’s rapid-response model is tailored for cases requiring prompt but non-emergency medical attention, offering a viable alternative to traditional clinical visits. The company also prioritizes patient data protection, transparent communication, and ethical medical practices, fostering trust in home-care environments. This initiative aligns with Dubai’s broader vision of creating a connected healthcare ecosystem that emphasizes accessibility and clinical integrity.
Residents can now explore services or schedule appointments directly through the Call My Doctor website. This development is expected to enhance the efficiency of home-based healthcare in Dubai, providing patients with greater flexibility in managing their medical needs.
-

MacArthur Foundation awards $100M to outbreak surveillance network, a boost amid global health cuts
The MacArthur Foundation has announced a $100 million grant to Sentinel, an African-led initiative focused on pandemic prevention and infectious disease surveillance. This significant investment comes at a critical time when global health funding is dwindling, particularly from major donor nations. Sentinel, a project that develops cost-effective pathogen detection tests, employs real-time outbreak tracking tools, and trains local scientists, has already trained over 3,000 public health workers across 53 African countries. The funding will enable Sentinel to expand its reach over the next five years, enhancing its ability to detect and respond to emerging diseases swiftly. Christian Happi, co-director of Sentinel, emphasized that this initiative demonstrates Africa’s leadership in addressing global health challenges through trust, collaboration, and community-driven systems. The MacArthur Foundation’s 100&Change competition, which aims to inspire bold philanthropic endeavors, selected Sentinel for its innovative and impactful approach. Chris Cardona, the foundation’s managing director, highlighted the importance of international funding, especially for projects like Sentinel that build cross-country capacity. However, global health programs face increasing challenges as donor countries reduce multilateral support. For instance, Gavi, a public-private vaccine alliance, faces funding shortfalls due to cuts by the U.S. government. Similarly, the U.S. Centers for Disease Control and Prevention has scaled back collaboration with the World Health Organization, potentially hindering outbreak responses. Sentinel’s work, rooted in community engagement and advanced diagnostics, aims to empower local responders to detect and mitigate disease threats. Dr. Pardis Sabeti, a collaborator on the project, described the grant as transformative, stressing the need for continuous pandemic surveillance. Former USAID official Nidhi Bouri underscored the global responsibility to support diverse funding streams for health initiatives, as disease outbreaks have far-reaching consequences. This grant not only bolsters Sentinel’s efforts but also sets a precedent for philanthropy to address global health challenges collaboratively.
-

China CDC urges precaution against peak season for acute infectious diarrhea
As China enters the annual peak season for acute infectious diarrhea, the Chinese Center for Disease Control and Prevention (China CDC) has issued a public health advisory emphasizing the need for heightened precautions. The surge in cases, primarily driven by pathogens such as norovirus and rotavirus, poses significant risks, particularly to vulnerable populations like children and the elderly. Norovirus, which remains highly active from October through March, thrives in crowded environments such as schools, childcare centers, elderly care facilities, and hospitals. Symptoms of norovirus infection include nausea, vomiting, fever, abdominal pain, and diarrhea. While most patients recover within two to three days without specialized treatment, infants and elderly individuals with chronic conditions are at greater risk of severe complications. Rotavirus, which peaks around September, predominantly affects young children, causing symptoms such as diarrhea, vomiting, and fever. To mitigate these seasonal threats, health authorities recommend vaccinating children against rotavirus and maintaining rigorous hand hygiene practices. Additionally, nurseries and schools are advised to enforce strict health protocols for kitchen staff and caregivers, including wearing masks, practicing proper hand hygiene, and immediately stepping away from their duties if symptoms arise. These measures aim to curb the spread of these highly contagious viruses and protect public health during this critical period.
-

UAE to introduce nasal spray flu vaccine for first time: Emarat Al Youm
In a groundbreaking move, the United Arab Emirates (UAE) is set to introduce a nasal spray flu vaccine for the first time, as reported by Emarat Al Youm. This innovative needle-free option will be available in both public and private healthcare centers and hospitals across the country, marking a significant expansion in the nation’s immunization strategy. The vaccine, which covers the same flu strains as the traditional injectable version, is designed for healthy individuals aged 2 to 49 years old. It utilizes a live attenuated virus, making it an ideal choice for children and those who are apprehensive about needles. The Ministry of Health and Prevention emphasized that this new option aims to enhance vaccination coverage rates and provide safe, effective alternatives for the community. Dr. Nada Al Marzouqi, Director of the Public Health and Prevention Department, highlighted that the nasal spray vaccine first received U.S. FDA approval in 2003 for ages 5 to 49, with the age range later extended to include children as young as 2 in 2007. However, the vaccine is not recommended for certain groups, including children under 2, adults over 50, pregnant women, individuals with immune disorders, and those with specific chronic diseases. For these groups, the injectable vaccine or other physician-recommended options remain the preferred choice. The Ministry assured that the nasal spray vaccine is registered in the UAE and subject to rigorous pharmaceutical oversight, with approvals from global regulatory bodies such as the FDA, WHO, and EMA. Additionally, the UAE’s pharmacovigilance program will monitor the vaccine’s side effects and effectiveness to ensure the highest standards of safety and quality.
-

Eswatini is the first African country to get twice-yearly HIV prevention shot
Eswatini has made history by becoming the first African nation to introduce lenacapavir, a revolutionary twice-yearly HIV prevention injection. Developed by Gilead Sciences, this groundbreaking drug has shown near-total protection in clinical trials and is hailed as a transformative tool in combating HIV, a virus that has claimed millions of lives across the continent. The rollout is part of the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR), in collaboration with the Global Fund, aiming to benefit at least 2 million people in 10 high-risk African countries by 2027. Eswatini, with the world’s highest HIV incidence, received the drug in the same year as its U.S. approval, marking a significant milestone. Zambia also received its first shipment, while regulatory approvals are pending in Botswana, Kenya, Malawi, Namibia, Rwanda, Tanzania, Uganda, and Zimbabwe. The U.S. initially planned to distribute 250,000 doses in 2024 but increased this to 325,000 due to high demand. In Eswatini, approximately 6,000 high-risk individuals, particularly mothers and newborns, will benefit from the initial rollout. Despite its potential, concerns over limited supplies and manufacturing rights have sparked debates, with South Africa’s health minister highlighting the need for broader access. Gilead has significantly reduced the drug’s price for lower-income countries, making it more accessible. However, civil society groups in South Africa have criticized the exclusion of local manufacturers from licensing agreements, despite their contributions to clinical trials.
-

Transformation of healthcare in China’s Xizang region celebrated
The Xizang Autonomous Region has witnessed a transformative leap in its healthcare system, thanks to a robust medical aid initiative launched by China’s central government. Since 2015, over 2,400 medical professionals have been dispatched in 11 groups to hospitals across the region, marking a significant milestone in improving healthcare delivery in one of the country’s most geographically challenging areas. The program, initially introduced at the sixth central symposium on Xizang-related work in August 2015, initially focused on supporting the Xizang Autonomous Region People’s Hospital and seven municipal-level hospitals. By August 2021, the initiative expanded to include 13 county-level hospitals, further amplifying its impact. Tan Xiangdong, deputy director of Xizang’s health commission, highlighted the program’s focus on cultivating medical disciplines, nurturing local talent, and advancing high-altitude medical research. The results have been profound: the maternal mortality rate dropped from 108.86 per 100,000 in 2014 to 48 per 100,000 by 2020, while the infant mortality rate fell from 16.81 per 1,000 to 7.6 per 1,000 over the same period. Additionally, the average life expectancy in Xizang rose to 72.19 years by the end of 2020, representing the highest growth rate nationwide. This initiative underscores the central government’s commitment to equitable healthcare development and has set a benchmark for medical aid programs in remote regions.
